Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
180
archived clinical trials in
Hair Loss

Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata
Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata
Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Intralesional Steroids in the Treatment of Alopecia Areata
A Phase 4 Multicenter, Randomized, Placebo Controlled Trial of 3 Doses of Intralesional Triamcinolone (KENALOG®) In the Treatment of Mild to Moderate Patch Type Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Intralesional Steroids in the Treatment of Alopecia Areata
A Phase 4 Multicenter, Randomized, Placebo Controlled Trial of 3 Doses of Intralesional Triamcinolone (KENALOG®) In the Treatment of Mild to Moderate Patch Type Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Intralesional Steroids in the Treatment of Alopecia Areata
A Phase 4 Multicenter, Randomized, Placebo Controlled Trial of 3 Doses of Intralesional Triamcinolone (KENALOG®) In the Treatment of Mild to Moderate Patch Type Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center / Department of Dermatology
mi
from
New York, NY
Intralesional Steroids in the Treatment of Alopecia Areata
A Phase 4 Multicenter, Randomized, Placebo Controlled Trial of 3 Doses of Intralesional Triamcinolone (KENALOG®) In the Treatment of Mild to Moderate Patch Type Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center / Department of Dermatology
mi
from
New York, NY
Click here to add this to my saved trials
Scalp Cooling to Prevent Chemo-induced Hair Loss
Scalp Cooling for Alopecia Prevention (SCALP)
Status: Enrolling
Updated:  12/31/1969
Hematology/Oncology Associates of Northern New Jersey, P.A.
mi
from
Morristown, NJ
Scalp Cooling to Prevent Chemo-induced Hair Loss
Scalp Cooling for Alopecia Prevention (SCALP)
Status: Enrolling
Updated: 12/31/1969
Hematology/Oncology Associates of Northern New Jersey, P.A.
mi
from
Morristown, NJ
Click here to add this to my saved trials
Scalp Cooling to Prevent Chemo-induced Hair Loss
Scalp Cooling for Alopecia Prevention (SCALP)
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Scalp Cooling to Prevent Chemo-induced Hair Loss
Scalp Cooling for Alopecia Prevention (SCALP)
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Scalp Cooling to Prevent Chemo-induced Hair Loss
Scalp Cooling for Alopecia Prevention (SCALP)
Status: Enrolling
Updated:  12/31/1969
Texas Oncology - Medical City Dallas
mi
from
Dallas, TX
Scalp Cooling to Prevent Chemo-induced Hair Loss
Scalp Cooling for Alopecia Prevention (SCALP)
Status: Enrolling
Updated: 12/31/1969
Texas Oncology - Medical City Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Scalp Cooling to Prevent Chemo-induced Hair Loss
Scalp Cooling for Alopecia Prevention (SCALP)
Status: Enrolling
Updated:  12/31/1969
Texas Oncology-Baylor Charles A. Sammons Cancer Center
mi
from
Dallas, TX
Scalp Cooling to Prevent Chemo-induced Hair Loss
Scalp Cooling for Alopecia Prevention (SCALP)
Status: Enrolling
Updated: 12/31/1969
Texas Oncology-Baylor Charles A. Sammons Cancer Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Scalp Cooling to Prevent Chemo-induced Hair Loss
Scalp Cooling for Alopecia Prevention (SCALP)
Status: Enrolling
Updated:  12/31/1969
USOncology / Texas Oncology-Memorial City
mi
from
Houston, TX
Scalp Cooling to Prevent Chemo-induced Hair Loss
Scalp Cooling for Alopecia Prevention (SCALP)
Status: Enrolling
Updated: 12/31/1969
USOncology / Texas Oncology-Memorial City
mi
from
Houston, TX
Click here to add this to my saved trials
Scalp Cooling to Prevent Chemo-induced Hair Loss
Scalp Cooling for Alopecia Prevention (SCALP)
Status: Enrolling
Updated:  12/31/1969
Lester and Sue Smith Breast Center at Baylor College of Medicine
mi
from
Houston, TX
Scalp Cooling to Prevent Chemo-induced Hair Loss
Scalp Cooling for Alopecia Prevention (SCALP)
Status: Enrolling
Updated: 12/31/1969
Lester and Sue Smith Breast Center at Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Scalp Cooling to Prevent Chemo-induced Hair Loss
Scalp Cooling for Alopecia Prevention (SCALP)
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Scalp Cooling to Prevent Chemo-induced Hair Loss
Scalp Cooling for Alopecia Prevention (SCALP)
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Minoxidil Response Testing in Females With Female Pattern Hair Loss
Minoxidil Response Testing in Females With Female Pattern Hair Loss
Status: Enrolling
Updated:  12/31/1969
Physicians Hair Institute
mi
from
Tucson, AZ
Minoxidil Response Testing in Females With Female Pattern Hair Loss
Minoxidil Response Testing in Females With Female Pattern Hair Loss
Status: Enrolling
Updated: 12/31/1969
Physicians Hair Institute
mi
from
Tucson, AZ
Click here to add this to my saved trials
Minoxidil Response Testing in Females With Female Pattern Hair Loss
Minoxidil Response Testing in Females With Female Pattern Hair Loss
Status: Enrolling
Updated:  12/31/1969
Tennessee Clinical Research Center
mi
from
Nashville, TN
Minoxidil Response Testing in Females With Female Pattern Hair Loss
Minoxidil Response Testing in Females With Female Pattern Hair Loss
Status: Enrolling
Updated: 12/31/1969
Tennessee Clinical Research Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Minoxidil Response Testing in Females With Female Pattern Hair Loss
Minoxidil Response Testing in Females With Female Pattern Hair Loss
Status: Enrolling
Updated:  12/31/1969
Sinclair Dermatology
mi
from
East Melbourne,
Minoxidil Response Testing in Females With Female Pattern Hair Loss
Minoxidil Response Testing in Females With Female Pattern Hair Loss
Status: Enrolling
Updated: 12/31/1969
Sinclair Dermatology
mi
from
East Melbourne,
Click here to add this to my saved trials
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
New Haven, CT
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Miami, FL
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Boston, MA
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Clinton Township, MI
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Clinton Township, MI
Click here to add this to my saved trials
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fridley, MN
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fridley, MN
Click here to add this to my saved trials
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Minneapolis, MN
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Winston-Salem, NC
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Cleveland, OH
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Portland, OR
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Austin, TX
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Houston, TX
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Norfolk, VA
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Birmingham, AL
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Hot Springs, AR
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hot Springs, AR
Click here to add this to my saved trials
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Trumbull, CT
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Trumbull, CT
Click here to add this to my saved trials
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Beverly, MA
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Beverly, MA
Click here to add this to my saved trials
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fort Gratiot, MI
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fort Gratiot, MI
Click here to add this to my saved trials
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Katy, TX
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Katy, TX
Click here to add this to my saved trials
LEO 124249 Ointment in the Treatment of Alopecia Areata
Efficacy of Twice Daily Applications of LEO 124249 Ointment 30mg/g for 12 Weeks to Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Northwestern University
mi
from
Evanston, IL
LEO 124249 Ointment in the Treatment of Alopecia Areata
Efficacy of Twice Daily Applications of LEO 124249 Ointment 30mg/g for 12 Weeks to Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Northwestern University
mi
from
Evanston, IL
Click here to add this to my saved trials
LEO 124249 Ointment in the Treatment of Alopecia Areata
Efficacy of Twice Daily Applications of LEO 124249 Ointment 30mg/g for 12 Weeks to Subjects With Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
The Icahn School of Medicine, Mount Sinai Hospital
mi
from
New York, NY
LEO 124249 Ointment in the Treatment of Alopecia Areata
Efficacy of Twice Daily Applications of LEO 124249 Ointment 30mg/g for 12 Weeks to Subjects With Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
The Icahn School of Medicine, Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata
A Randomized Placebo-controlled Single Center Pilot Study of the Safety and Efficacy of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata
Status: Enrolling
Updated:  12/31/1969
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata
A Randomized Placebo-controlled Single Center Pilot Study of the Safety and Efficacy of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata
Status: Enrolling
Updated: 12/31/1969
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Status: Enrolling
Updated:  12/31/1969
Yale-New Haven Hospital
mi
from
New Haven, CT
Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Status: Enrolling
Updated: 12/31/1969
Yale-New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
Burke Pharmaceutical Research
mi
from
Hot Springs, AR
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
Burke Pharmaceutical Research
mi
from
Hot Springs, AR
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
Petrus Center for Aesthetic Surgery & Hair Transplantation
mi
from
Little Rock, AR
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
Petrus Center for Aesthetic Surgery & Hair Transplantation
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
Therapeutics Clinical Research
mi
from
San Diego, CA
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
Therapeutics Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
Minnesota Clinical Study Center
mi
from
Fridley, MN
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
Minnesota Clinical Study Center
mi
from
Fridley, MN
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
NW Dermatology & Research Center, LLC
mi
from
Portland, OR
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
NW Dermatology & Research Center, LLC
mi
from
Portland, OR
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
Oregon Medical Research Center, PC
mi
from
Portland, OR
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
Oregon Medical Research Center, PC
mi
from
Portland, OR
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
DermResearch, Inc.
mi
from
Austin, TX
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
DermResearch, Inc.
mi
from
Austin, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
Suzzane Bruce and Associates P.A., The Center for Skin Research
mi
from
Katy, TX
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
Suzzane Bruce and Associates P.A., The Center for Skin Research
mi
from
Katy, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
The Education and Research Foundation, Inc.
mi
from
Lynchburg, VA
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
The Education and Research Foundation, Inc.
mi
from
Lynchburg, VA
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
Heartland Research Associates, LLC
mi
from
Wichita, KA
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
Heartland Research Associates, LLC
mi
from
Wichita, KA
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
Michigan Center for Skin Care Research
mi
from
Clinton Township, MI
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
Michigan Center for Skin Care Research
mi
from
Clinton Township, MI
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
Radiant Research
mi
from
Santa Rosa, CA
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
Radiant Research
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
DeNova Research
mi
from
Chicago, IL
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
DeNova Research
mi
from
Chicago, IL
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
University of Minnesota Department of Dermatology Division of Clinical research
mi
from
Minneapolis, MN
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
University of Minnesota Department of Dermatology Division of Clinical research
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated:  12/31/1969
Wake Forest University Health Sciences Department of Dermatology Medical Center Boulevard
mi
from
Winston-Salem, NC
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Status: Enrolling
Updated: 12/31/1969
Wake Forest University Health Sciences Department of Dermatology Medical Center Boulevard
mi
from
Winston-Salem, NC
Click here to add this to my saved trials